Published Date: 16 Feb 2023
Chatbots have shields to control misinformation, but it will continue to be a game.
Read Full News1.
Nearly 4 million lung cancer deaths averted and 76 million years of life gained due to tobacco control in US
2.
Increased Data Support Active Monitoring for Low-Risk Prostate Cancer.
3.
Momelotinib, a JAK inhibitor, has FDA approval to treat adult myelofibrosis in anemic patients.
4.
Lentiviral Gene Therapy Shows Promise in Severe Hemophilia A
5.
Earlier Info on Financial Stress; Obesity and Second Cancers; Carcinogenic Condoms?
1.
Cutting-Edge Cancer Treatments: Innovations and Outcomes in Non-Hodgkin Lymphoma
2.
Essential Applications in Oncology in Daily Practice
3.
Comprehensive Concepts in Oncology in Clinical Decision-Making
4.
Exploring the Latest Advances in PTLD Cancer Treatment
5.
The Mystery of Carotid Body Tumors: The Facts You Need to Know
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management
2.
Should We Use DARA Up Front As First-Line Therapy in MM?
3.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
4.
CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion
5.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation